The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - AstraZeneca; Bristol-Myers Squibb; PharmaMar
Consulting or Advisory Role - Tesaro
Travel, Accommodations, Expenses - PharmaMar; Roche
 
Consulting or Advisory Role - Advaxis; Amgen; AstraZeneca; Bayer; Cerulean Pharma; Debiopharm Group; GCI Health; Genmab; ImmunoGen; Janssen-Cilag; Lilly; Mateon Therapeutics; Merck Sharp & Dohme; Morphotek; Nektar; Novartis; Novocure; Oncoinvent; Oxigene; Pfizer; Roche; Roche; Theradex Ltd; Vifor Pharma
Research Funding - Amgen; Roche
Travel, Accommodations, Expenses - Elsevier; Tesaro; Theradex
ATALANTE (ENGOT-ov29): A randomized, double-blinded, phase III study of atezolizumab versus placebo in patients with late relapse of epithelial ovarian, fallopian tube, or peritoneal cancer treated by platinum-based chemotherapy and bevacizumab.
 
Jean Emmanuel Kurtz
No Relationships to Disclose
 
Christian Marth
No Relationships to Disclose
 
Ana Oaknin
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; PharmaMar; Roche; Tesaro
Travel, Accommodations, Expenses - AstraZeneca; PharmaMar; Roche
 
Bernard Asselain
Honoraria - Bristol-Myers Squibb; Ipsen; Roche
Consulting or Advisory Role - Roche
 
Klaus H. Baumann
No Relationships to Disclose
 
David Cibula
No Relationships to Disclose
 
Ignace Vergote
No Relationships to Disclose
 
Tally Levy
No Relationships to Disclose
 
Eric Pujade-Lauraine
Honoraria - AstraZeneca; Clovis Oncology; Pfizer; Roche; Tesaro
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Pfizer; Roche; Tesaro
Travel, Accommodations, Expenses - AstraZeneca; Clovis Oncology; Roche